NGVTNYSEChemicals & Allied ProductsFiscal year ends December 31

Ingevity Corp

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026

$70.31+0.49 (+0.70%)

Close on Oct 19, 2026

Margins

Share of revenue, fiscal years 2013 to 2025

39.5%+1.2 pts over 5 years

35.9%+3.1 pts over 5 years

-14.3%−29.2 pts over 5 years

Compound annual growth to fiscal 2025

Per year	1 year	3 years	5 years	10 years
Revenue	-2.7%	-11.2%	-0.8%	+2.0%
Gross profit	-0.7%	-6.8%	-0.2%	+5.3%
Operating income	-1.7%	-2.6%	+1.0%	+9.7%
Free cash flow	+436.3%	+17.0%	+0.2%	–

10 fiscal years. Hover a measure to see how it is calculated.

Measure	FY2016	FY2020	FY2025
Return on equity	11.0%	30.9%	-148.6%
Return on assets	4.4%	8.1%	-9.1%
Current ratio	2.16	2.81	1.33
Debt to equity	3.85	2.01	40.69
Net debt to EBITDA	2.26×	2.07×	2.15×
Interest coverage	8.5×	8.4×	5.3×
Inventory turnover	4.2×	3.7×	3.7×
Capex to revenue	6.2%	6.8%	4.9%
Diluted shares	42M	42M	36M

Return on equity split into margin, efficiency and leverage

Net margin-14.3%

Asset turnover0.64×

Equity multiplier16.33×

Return on equity, FY2025-148.6%

Fiscal year	Net margin	Asset turnover	Equity multiplier	Return on equity
FY2025	-14.3%	0.64×	16.33×	-148.6%
FY2024	-35.9%	0.52×	5.62×	-104.1%
FY2023	-0.4%	0.45×	4.03×	-0.8%
FY2022	12.7%	0.64×	3.79×	30.8%
FY2021	8.5%	0.58×	3.65×	17.9%
FY2020	14.9%	0.54×	3.82×	30.9%
FY2019	14.2%	0.75×	3.98×	42.3%
FY2018	14.9%	1.01×	3.64×	54.8%
FY2017	13.0%	1.10×	4.35×	62.5%
FY2016	3.9%	1.13×	2.52×	11.0%